Bristol-Myers Squibb

Home

Understanding HCM

Our Pipeline

Bristol Myers Squibb

Mavacamten MOA

This site is intended for US Health Care Professionals only.

Mavacamten Mechanism of Action

The safety and efficacy of mavacamten, an investigational agent, have not been established.

Bristol-Myers Squibb

© 2021 MyoKardia, Inc, a wholly owned subsidiary of Bristol-Myers Squibb™. All rights reserved. CV-US-2100443 08/21